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Background. ‘‘Timing’’ processes are mediated via a disturbed neuronal network including the basal ganglia. Brain structures
important for ‘‘timing’’ are also discussed to be critical for the deterioration of movements in Huntington’s disease (HD).
Changes in ‘‘timing processes’’ are found in HD, but no study has varied the degree of motor demands in timing functions in
parallel in HD. It may be hypothesized that timing functions may be deteriorated to a different extent in motor and non-motor
timing, because in motor timing the underlying brain structures may be more demanding than in non-motor timing.
Methodology/Principle Findings. We assessed timing in two different experiments: a time-estimation (TE) and a time-
discrimination (TD) task. The demand on motor functions is high in the TE-task and low in the TD-task. Furthermore, general
motor ability was assessed at different complexity levels. A presymptomatic (pHD), a symptomatic (HD) and a control group
were investigated. We found a decline in timing functions when demands on the motor system were high (TE-task), in HD and
even in pHD, compared to controls. In non-motor timing (TD task) and in the assessment of general motor ability, performance
in the pHD-group was comparable to the controls and better than in the symptomatic group. Performance in both timing tasks
was related to the duration until the estimated age of onset in pHDs. Conclusions/Significance. The study shows a selective
deterioration of time-estimation processes in symptomatic and even presymptomatic Huntington’s disease. Time-
discrimination processes were not affected in both patient groups. The relation of timing performance to the duration until
the estimated age of onset in pHD is of clinical importance.
Citation: Beste C, Saft C, Andrich J, Mu ¨ller T, Gold R, et al (2007) Time Processing in Huntington’s Disease: A Group-Control Study. PLoS ONE 2(12):
e1263. doi:10.1371/journal.pone.0001263
INTRODUCTION
Huntington’s disease (HD) is an autosomal dominant, monogentic
neurological disorder causing a degeneration of the neostriatum.
The disease is genetically expressed by an extension of the CAG-
repeat length at the 4th chromosome [1] encoding a large protein,
the ‘‘huntingtin’’. This protein accumulates and causes apoptotic
striatal neuronal death [2]. The most obvious sign of HD is
chorea: i.e. rapid, arrhythmic and complex involuntary move-
ments. Especially cortico-striatal circuits [e.g. 3] are affected in
Huntington’s disease (HD). It is the degeneration of medium spiny
neurons (MSPs), which is discussed to be a critical factor in HD
[4,5], but also the dysfunction of the supplementary motor area
(SMA) [6] and the dopamine system [7] are important. These
brain systems are also affected in the preclinical stage of HD
(pHD) [e.g. 3], even though the preclinical stage is characterized
by an absence of specific motor signs. Along with the occurrence of
irregular dyskinesia, voluntary movements are also deteriorated.
Yet the nature of this kind of impairment is not well understood
[8], but is of great importance for the patients lives [9].
Optimal motor functioning requires a highly precise timing of
the coordination of muscles involved in a movement. If timing
functions are crucial, it may be speculated that deficits in cognitive
timing functions may underly the voluntary movement distur-
bances in HD. This seems likely, since ‘‘time processing’’ is
mediated via brain systems that are affected in HD and important
for movement execution: i.e. cortico-striatal circuits, especially the
MSPs, the SMA and the dopamine system [10–13]. Indeed,
dysfunctions in timing processes are found in HD [e.g. 14, 15], but
no study has varied the role of motor demands in timing functions
in parallel in HD, to estimate the importance of these processes for
voluntary movement dysfunctions in HD. This can be achieved by
assessing performance in two different timing tasks: ‘‘time-
estimation (TE)’’ and ‘‘time-discrimination (TD)’’. TE may
comprise the ‘‘production’’ of a time interval (e.g. by pressing
a button, when a predefined time-period has elapsed). In TD,
intervals are defined by stimuli (e.g. tones marking the beginning/
ending of the interval) and judged against a standard interval.
Thus, precise motor timing is less important in this task, compared
to the TE-task (see ‘‘Description of Procedures’’ for more details).
Additionally we conducted two other tests assessing general motor
performance; a ‘‘continuous reaction task (CRT)’’, and a ‘‘tapping
task (TA)’’ [16] to control effects in motor (TE) and non-motor
(TD) embedded timing. If the assessment of timing processes
allows an estimation of the integrity of fronto-striatal networks
affected in HD, one may assume that performance in these tasks
may be related to clinically relevant parameters of disease
progression (i.e. the estimated age of onset (eAO) in presymptom-
atic HD).
In summary, the study aimed at assessing timing processes with
varying demands on the motor system in presymptomatic (pHD),
symptomatic HD (HD) and healthy controls. Furthermore the
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dysfunctions in HD will be investigated. Finally we want to explore
the value of the assessment of timing for the diagnosis of HD.
The results show a selective deterioration of time-estimation
processes in presymptomatic Huntington’s disease. Time-discrim-
ination processes, as well as general motor performance were not
dysfunctional, compared to healthy controls. In the pHD-group
performance in the TE and TD-task was related to the estimated
age of onset (eAO). In the HD-group, performance was poor in all
tasks.
METHODS
Objectives
The aim of this study was to assess to assess timing processes with
varying demands on the motor system in presymptomatic (pHD),
symptomatic HD (HD) and healthy controls to estimate if the
assessment of timing of timing functions may be of clinical value in
the diagnosis of HD.
Participants
A group of twelve right-handed presymptomatic gene mutation
carriers defined by a positive gene test and absence of clinical
symptoms (pHD, N=12) from 22 to 52 years of age (M=35.91;
SD=10.03) were recruited. The mean CAG-length was 42.58
(SD=1.78; range=39–46). Calculation of the estimated age of
onset (eAO) [17] revealed a mean eAO of 45.53 (SD=4.6;
range=37.5–53.2). The duration until estimated age of onset
(eAO) was calculated by subtracting the actual age of the patient at
time of testing from the calculated eAO and revealed a mean
duration of 10.13 (SD=8.1, range=23.4–23.8) (Note: negative
values in this calculation indicate, that the calculated eAO has
already been passed; whereas positive values indicate that the eAO
has not passed, according to the estimation by Ranen et al. [17]).
Additionally, a group of ten unmedicated symptomatic gene
mutation carries (HD, N=10) from 21 to 57 years of age
(M=36.50, SD=10.20) were recruited. The mean CAG-length
was 47.10 (SD=5.4; range=40–56). The mean age of onset (AO)
was 34.20 (SD=11.5, range=17–56). All patients (pHD, HD)
agreed to be videotaped to document their neurological status.
Scores for each group (pHD, HD) of the UHDRS-motor score,
UHDRS cognitive score, TFC, IS, MMSE, BDI and YMRS are
given in Table 1. Furthermore, a group of twelve age- and gender-
matched healthy controls (N=12) from 23 to 52 years of age
(M=36.5, SD=8.6) were recruited. See also Table 1 for further
details.
Description of Procedures or Investigations
Undertaken
In this study four different tasks were performened. Two tasks
were designed to assess timing functions (time estimation (TE);
time discrimination (TD), two tasks were designed to assess general
motor functions (continuous reaction task (CRT); tapping (TA).
The tasks are described in detail, below. The sequence of
conducted tests (TE, TD, CRT, TA) was counterbalanced in all
groups. All four tasks were trained by the subjects until stable
performance was reached.
Time estimation (TE)
In this task subjects were presented with a white square
(2.562.5 cm size) on a black computer screen. Subjects were
required to press a response key as exactly as possible at 1200 ms
after onset of a stimulus (a square). This time, which includes the
estimated time for the motor response, had to be estimated by the
subjects, i. e. the motor response defines the length of the time
interval. Feedback was given if the response was made in a time
range from 1000–1400 ms or not. If the response was made within
that time range, positive feedback was given. If not, negative
feedback was given; 120 trials were conducted.
Time discrimination (TD)
Time discrimination was assessed using a two-alternative-forced-
choice paradigm. At the beginning of this task white letters ‘‘S’’
and ‘‘L’’ (2.562.5 cm size) were presented on a black computer
Table 1. Descriptive demographical and clinical data of the symptomatic group (HD), presymptomatic group (pHD) and control
group (controls).
..................................................................................................................................................
HD pHD Controls
mean (SD) range mean (SD) range mean (SD) range
Sample size N=11 N=14 N=12
Male:female ratio 6 m:5 f T m:7 f 6 m:6 f
Age (years) 36.50 (10.20) 21–57 35.91 (10.03) 22–52 36.50 (8.64) 23–52
CAG-repeat length 47.10 (5.42) 40–56 42.58 (1.78) 39–46 NA
Age of onset (AO) 34.20 (11.51) 17–56 NA NA
Estimated age of onset (eAO) 36.99 (11.39) 21–52 (N=9) 45.53 (4.62) 37.5–53.3 NA
Duration until eAO 20.12 (7.94) 211.5–13.71 (N=9) 10.13 (8.19) 23.44–23.82 NA
UHDRS (motor score) 26.00 (12.1) 9–44 0 NA
TFC 11.70 (1.25) 9–13 13 NA
IS 86.50 (8.83) 70–100 100 NA
IQ 105.70 (7.66) 95–118 109.50 (11.86) 95–130 113.25 (8.86) 98–130
UHDRS (cognitive score) 165.40 (24.05) 137–215 236.50 (16.81) 209–259 249.50 (11.03) 236–266
MMSE 27.30 (2.26) 23–30 29.41 (0.51) 29–30 29.66 (0.5) 29–30
BDI 5.90 (4.06) 0–13 5.75 (4.43) 0–14 3.00 (3.43) 0–12
YMRS 3.30 (1.56) 1–5 1.33 (1.37) 0–4 1.36 (1.50) 0–5
doi:10.1371/journal.pone.0001263.t001
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PLoS ONE | www.plosone.org 2 December 2007 | Issue 12 | e1263screen. The stimuli differed in their duration of presentation. ‘‘S’’
was presented for 1000 ms and ‘‘L’’ was presented for 1200 ms.
The subjects had to react with the left hand on ‘‘S’’-presentations
and with the right hand on ‘‘L’’-presentations. After the subjects
were familiar with the different presentation times of ‘‘S’’ and ‘‘L’’
they underwent 120 trials, in which the letter ‘‘H’’ was presented
instead of ‘‘S’’ and ‘‘L’’. The presentation times of ‘‘H’’ randomly
changed between 1000 ms and 1200 ms (60 trials 1000 ms; 60
trials 1200 ms) and the subjects had to decide using the
appropriate response, if the presentation of the letter ‘‘H’’ was
presented for a short (i.e. 1000 ms) or long period (i.e. 1200 ms).
This decision had to be carried out after the stimulus was
presented. Thus the time interval is not defined by a precise motor
response, making timing not as heavily dependent on precise
motor function as in the TE-task.
Continuous reaction task (CRT)
In this task subjects were presented with white arrowheads (2 cm
horizontal and vertical size), either pointing to the left or to the
right. The subjects were required to react with the left hand when
the arrowhead pointed to the left and with the right hand when the
arrowhead pointed to the right. 60 arrowheads pointed in the left
and 60 pointed to the right direction. The subjects were required
to respond as fast as possible.
Tapping (TA)
This task assesses simple movements [16]. Subjects were instructed
to tap as quickly as possible on a computer-based contact board
(363 cm) with a contact pencil for a period of 32 seconds after the
initial flash of a yellow stimulus light. The board was positioned in
the centre. When performing the task, elbows were allowed to be
in contact with the table. The number of contacts was measured
[16]. For statistical analysis performance the absolute frequency of
taps was collapsed over the left and right hand. Additionally, the
intertap-interval was calculated by dividing the time period of
tapping (64 seconds for both hands) by the absolute frequency of
performed taps.
Ethics
Asymptomatic gene carriers as well as symptomatic patients were
recruited from the local Huntington Centre of the Neurological
Clinic of the University of Bochum. They were selected on the
basis of pre-clinical counselling in the case of asymptomatic gene
mutation carries or on the basis of routine clinical counselling in
the case of symptomatic patients. Healthy controls were recruited
by newspaper announcements. All participants gave written
informed consent. For the symptomatic individuals, a family
member was aware of the recruitement for the study and was
involved in the consent procedure. The study was approved by the
ethics committee of the University of Bochum.
Statistical methods
Data from twelve presymptomatic gene mutation carriers (pHD)
(N=12), ten symptomatic subjects (HD) (N=10) and twelve
healthy controls (N=12) was analyzed. There were no drop-outs.
For the TE- and TD-task the number of error trials was analyzed.
For the CRT-task the mean reaction time across all trials was
analyzed. For the tapping task (TA) the mean number of
performed taps as well as the intertap-interval was analyzed.
Tests of normal distribution within each group using the
Kolmogorov-Smirnov test revealed that each variable included
to the ANOVAs and correlational analysis was normal distributed
(all z,0.877; P ..425; one-tailed). The TE- and TD-task were
analyzed in a repeated-measures ANOVA using the within-subject
factor ‘‘experiment’’ (TE vs. TD) and the between-subject factor
group (controls, pHD, HD). Both the CRT- as well as the tapping
task (TA) were analyzed using separate univariate ANOVAs with
the between-subject factor group (controls, pHD, HD). The
degrees of freedom were adjusted using the Greenhouse-Geisser-
Correction when appropriate. Significances are given one-tailed,
due to higher test-power. In addition effect sizes (g) are reported.
The mean and standard deviation (6SD) are given. Post-hoc tests
were calculated using the Bonferroni-correction. Due to higher test
power, one-sided tests were performed. For statistical analysis
SPSS 11.0 was used.
RESULTS
Results of the performance in each test are given in Figure 1.
Analyzing the TE- and TD-task, the main-effect ‘‘group’’
(F(2,31)=66.40; p,.001; g=.81) showed that the number of
errors increased from controls (36.58616.23) to pHD
(50.58627.08) and HD (79.05611.20). The main-effect ‘‘exper-
iment’’ (F(1,31)=166.29; p,.001; g=.84), showed poorer perfor-
mance (i.e. more errors) in the TE-task (68.48617.60) than in the
TD-task (40.26626.02). Both effects interacted with each other
(F(1,30)=37.05; p,.001; g=.70). Subsequent univariate ANO-
VAS revealed a group-effect in both tasks (TE: F(2,31)=20.83;
p,.001; g=.57; TD: (F(2,31)=128.01; p,.001; g=.89). Post-hoc
tests for the TE-task showed that controls (50.3368.02) performed
better than both HD-groups (pHD: 74.33612.54; HD:
80.08614.63) (p,.001), which did not differ from each other
(p=.637) (Fig. 1a). For the TD-task pHDs and controls did not
differ from each other (pHD: 26.83612.08; controls: 22.8368.64)
(p=.461), and both performed better than the HD-group
(77.3066.65) (P,.001) (Fig. 1b). For the TD-task, performance
was tested against chance level and it was shown that in each
group performance was different from chance level (controls:
t12=214.89 p,.001; pHD: t12=210.68 p,.001; HD: t10=8.22
p,.001; all one-tailed).
The CRT-task also revealed a group-effect (F(2,31)=21.59;
p,.001; g=.58) with the pHDs and controls not differing from
each other (controls: 336.5638.7; pHD: 353.5629.2) (p..9), but
performing better than the HD-group (518.6644.21) (p,.001)
(Fig. 1c). The same pattern was also found for the absolute
frequency of taps in the TA-task (Fig. 1d) (F(2,31)=15.55; p,.001;
g=.50) with pHDs and controls not differing from each other
(controls: 183617.6; pHD: 177616.1) (p ..9), and performing
better than the HD-group (137627.2) (p,.001). For the calculated
inter-tap interval there was the same effect than for absolute
frequencies (F(2,31)=19.45; p,.001) with the pHDs and controls
not differing from each other (controls: 352.46615.11; pHD:
363.39615.13) (p..9) and performing better than the HD-group
(480.43616.55) (p,.001).
In pHDs performance in the TE and the TD tasks was related
to the duration until the eAO in the pHDs [17] (TE: r=2.689,
P=.007; TD: r=2.502, p=.048) (refer: Figure 2), while
performance in CRT (r=2.089, p=.391), tapping (absolute taps:
r=2.200, p=.266; intertap-interval: r=2.172, p=.279) was not.
In sum, both HD-groups showed comparable performance in
motor embedded timing (TE) and performed more poorly than the
control group, while in TD controls and pHDs showed
comparable performance [see: 15], which were better than those
of HD-group. The latter pattern was also found in the CRT- and
TA-task.
Timing in Huntington’s Disease
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The results suggest that in presymptomatic gene mutations carriers
(pHD) performance in the TE-task is deteriorated, while
performance in the TD-, CRT- and TA-task is still normal.
Additionally, performance in the timing tasks (i.e. TE- and TD-
task) was related to the estimated age of onset (eAO) in pHD. For
the symptomatic group (HD) performance was generally poor.
The result found for the TD-task is in line with the findings by
Paulsen et al. [15], who also reported no difference in behavioural
performance in this task, likely due to compensatory mechanisms
[15]. Yet data from the TE-task reveal that performance can
decline, even in pHD, if timing is embedded in motor processes.
The difference in results regarding the TD- and the TE-task
suggests that timing is not per se deteriorated in pHD, but it
becomes when timing is dependent on motor processes. Yet, if HD
wasa ‘‘time-perception’’ disorder, the pHD-group should have
performed poorly on both timing tasks, which was not the case. If
HD was a ‘‘motor timing’’ disorder performance in the CRT- and
TA-task may be different in the pHD-group, since motor timing is
also important in these tasks. This was likewise not the case.
However, performance in the TE-task was poor in pHDs,
suggesting for ‘‘motor timing’’ deficits. The critical point that
may dissociate the CRT- and TA-task from the TE-task is that in
the latter task, timing was at a larger timescale than in the CRT-
Figure 2. Relation of the performance in the TD and TE task to the duration until the estimated age of onset.
doi:10.1371/journal.pone.0001263.g002
Figure 1. Performance on the TE (a), TD (b), CRT-task (c) and tapping (d). In (a) and (b) the absolute frequency of errors is given (note: In TD,
performance differed from chance level), in (c) the mean reaction time, in (d) the number of taps are given, all with standard deviation (SD).
doi:10.1371/journal.pone.0001263.g001
Timing in Huntington’s Disease
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produced. Mean reactions times (RTs) in the CRT were more
than twice as short. This was also the case for the mean intertap-
interval in the TA-task. Therefore we assume that the motor
timing deficit in pHD depends on the length of the time interval.
Future studies should examine different time intervals in motor
timing tasks in order to determine the optimal length for detecting
early changes in HD.
Possible mechanisms
Regarding the ‘‘neuroanatomy of timing’’ striatal medium spiny
neurons (MSPs), the dopamine system and the SMA play a central
role in a network mediating time control [11,12]. Here medium
spiny neurons (MSPs) are most central. MSPs are assumed to
weight cortical and thalamic inputs, which carry ‘‘time-informa-
tion’’ from cortical neurons [11]. In cortical structures time
information is represented by neurons oscillating in activity at
a different rate [11]. These various activities impinge on striatal
MSPs. The assumed weighting functions of the MSPs are assumed
to serve as a filter mechanism through which coherent cortical
activity can elicit striatal firing only at the appropriate time.
However, besides the putative function of the MSPs for timing
functions, they are also important for execution of movements. As
stated in the introduction MSPs are affected in HD [5,6,7] and
assumed to relate to the appearance of motor dysfunctions [5,6]. It
is therefore hypothesized that in case of time estimation (TE) the
weighting processes mediated via the MSPs may interfere with the
concurrently occurring preparation of the voluntary movement
also partly mediated via the MSPs. Due to this putative
coincidence of weighting processes and motor preparation
processes the capacity of the MSPs may become overstrained in
pHDs leading to a decline in performance. In HD it is likely that
the capacity of the common part of the systems is reduced to an
extent that even ‘‘less demanding’’ processes [i.e. non-motor
timing (TD), motor performance (CRT, TA)] are performed
poorly. This is plausible since progressive neuropathology is
evident even in pHD [3,18]. However, the preceding discussion
focussed on the MSPs, but it should be noted that also the
dysfunctional dopamine system [3] and the dysfunctional SMA [6]
in HD play an important role in timing.
Correlational data
Despite performance in all tasks being poor in HD, only
performance in timing-tasks was inversely related to the duration
until the estimated age of onset (eAO) in pHDs [see: 15]. That is:
the nearer the eAO, the poorer was performance in the TE- as
well as in the TD-task. Thus, the estimated forthcoming time span
of preclinical disease progression, culminating in the onset of
movement dysfunctions (age of onset, AO) is related to alterations
in timing-processes, with these processes being more and more
affected the closer the eAO. This is underlined by the fact that
a relation to the duration until eAO was seen in both timing tasks
and thus independent of the demands on motor functions. Due to
this it may be speculated that ‘‘timing-processes’’ and their
deterioration may be another putative origin for the emergence of
motor symptoms in HD, besides alterations in error processing
[19], which have indeed been shown to be deficient in HD [20–
22].
Limitations
Future studies may incorporate larger sample sizes in order to
increase generalizability of results. What may also be critical in the
current study is, that CAG-repeat sizes differed between the
presymptomatic (pHD) and symptomatic group (HD), since
different CAG-repeat size may be accompanied by different
strengths of pathogenic processes. Yet, this was side effect of
matching the groups with respect to their age, since tasks assessing
cognitive timing functions are known to be age-sensitive. Since this
study was restricted to behavioural data, the precise brain
mechanisms underlying the observed pattern of results must
remain hypothetical.
Perspectives and Conclusion
In summary, the study shows a selective deterioration of time-
estimation processes in presymptomatic Huntington’s disease.
Time-discrimination processes were not affected. It may be
inferred that under special circumstances voluntary movements
can be deteriorated even in the preclinical stage of HD. These may
depend on the time-scale in which the movement takes place.
Furthermore, performance in the TE- and TD-task is related to
the duration until the likely onset of motor symptoms in HD.
Future studies may be done in a longitudinal manner to better
document the time course of preclinical disease progression and
strengthen clinical importance. This may also be an important step
in order to estimate if these easy and fast applicable tasks may be
implemented in large clinical trials.
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